2019 HIGHWe hit a high of $7.39 in May 2019 and now we have a more attractive well run company with cash on hand and a Pharma in a Legal Cannabis Country Germany.I think were going straight up from here.Also Canada is easing on their taxation and the US rescheduling will help Medipharm's Growth in Revenue and Profitability.I predict in a year or two we will be higher then $7.39